Funded Health Care Startups in Minneapolis
The disclosed deal sizes show a clear concentration at the top: Inbound Health’s $30M round (2023-09-20) is the only disclosed amount above $10M, while the…
The disclosed deal sizes show a clear concentration at the top: Inbound Health’s $30M round (2023-09-20) is the only disclosed amount above $10M, while the rest of the disclosed rounds cluster at $11M ($7M, $11M, and $11M entries) down to $3M. Another strong pattern is a late-2024/2023 clustering around large checks: Melodi closed $11M on 2024-08-29, Gem Health closed $7M on 2024-10-16, and Inbound Health’s $30M followed on 2023-09-20; meanwhile several other sizeable rounds stack in 2023 (e.g., Kyros $11M on 2023-08-23, Davenport SAF-T Systems is the only undisclosed amount on 2023-03-07).
Stage and disclosure mix is also uneven. Of 10 rows, 6 list “Series Unknown” (including Nice Healthcare $7M on 2025-06-24, Gem Health $7M on 2024-10-16, and Kyros $11M on 2023-08-23), 1 is explicitly “undisclosed” (Davenport SAF-T Systems, 2023-03-07), and the only disclosed non-Unknown stages are Series A (Melodi $11M, 2024-08-29) and Series B (Inbound Health $30M, 2023-09-20). All companies are listed in Minneapolis, and the displayed round dates span 2021-04-13 (NitriCap Medical) to 2025-06-24 (Nice Healthcare).
Most recent rounds
10 shownRelated listings
Frequently asked
What stands out in deal size for Health Care startups in Minneapolis—does any round dwarf the rest?
Inbound Health’s $30M round on 2023-09-20 is the only disclosed amount above $10M, with other disclosed rounds concentrated around $7M to $11M (e.g., Nice Healthcare $7M on 2025-06-24; Melodi $11M on 2024-08-29; Kyros $11M on 2023-08-23) down to $3M (Medical 21 $3M on 2022-09-15; NitriCap Medical $3M on 2021-04-13).
Are there visible time clusters among the most recent Minneapolis health care rounds?
Several higher-check rounds cluster across 2024–2023: Gem Health closed $7M on 2024-10-16, Melodi closed $11M on 2024-08-29, and Inbound Health closed $30M on 2023-09-20, with Kyros also closing $11M on 2023-08-23. In contrast, the earlier edge (2021–2022) includes multiple $7M/$3M-sized rounds such as Hidrate $7M on 2021-12-21 and Medical 21 $3M on 2022-09-15.
How dominant is “Series Unknown” versus named stages, and does the outlier Inbound Health fit the pattern?
Named stages appear in 2 of 10 rows: Melodi is listed as Series A ($11M on 2024-08-29) and Inbound Health as Series B ($30M on 2023-09-20). The remaining 7 rows are labeled “Series Unknown” (6 rows with disclosed amounts plus one undisclosed amount), making Inbound Health’s $30M the biggest disclosed deal among the named-stage subset rather than among “Series Unknown.”
Which companies are closest to the present date, and are there any unusually small rounds near the top?
Within the two most recent entries, Nice Healthcare raised $7M on 2025-06-24 and WeCare raised $10K on 2025-02-19. That $10K datapoint is dramatically smaller than the other disclosed amounts near the top of the list, including Gem Health’s $7M on 2024-10-16.
Is Minneapolis the only geography here, or do any entries deviate?
All 10 rows list the same city and state combination: Minneapolis, Minnesota, United States. There are no alternate cities or states shown in the data, so the geographic pattern is fully concentrated in Minneapolis.
Are there disclosure outliers besides deal size—such as undisclosed amounts?
Yes. Davenport SAF-T Systems (2023-03-07) is the only entry marked “undisclosed,” while every other non-Unknown example uses a disclosed dollar figure (e.g., Series B $30M for Inbound Health on 2023-09-20 and Venture/Series Unknown $7M for Hidrate on 2021-12-21).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.